Literature DB >> 2350238

Changes in urinary n-hexane metabolites by co-exposure to various concentrations of methyl ethyl ketone and fixed n-hexane levels.

E Shibata1, J Huang, Y Ono, N Hisanaga, M Iwata, I Saito, Y Takeuchi.   

Abstract

To make clear how the n-hexane metabolism is modified by co-exposure with MEK, rats were exposed to various concentrations of MEK mixed with a fixed concentration of n-hexane. Twenty-four male Wistar rats were divided into four equal groups. Each group was exposed for 8 h to 2000 ppm n-hexane, 2000 ppm n-hexane plus 200 ppm MEK, 2000 ppm n-hexane plus 630 ppm MEK and 2000 ppm n-hexane plus 2000 ppm MEK, respectively. Free metabolites and the sum of free and conjugated metabolites of n-hexane were analyzed by gas chromatography. The main metabolite was 2-hexanol during the exposure and 2,5-hexanedione (2,5-HD) after the exposure in any group. The main metabolites, 2-hexanol and 2,5 HD, decreased in inverse proportion to the co-exposed MEK concentrations. The results suggest that augmentation of n-hexane neurotoxicity by MEK co-exposure could not be explained only by 2,5-HD. In addition, 2,5-HD is recommended as an index for biological monitoring of n-hexane exposure. However, one should be careful to evaluate the exposed n-hexane concentration by urinary 2,5-HD, because n-hexane metabolism could be largely modified by co-exposure with MEK.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350238     DOI: 10.1007/bf01974405

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  10 in total

1.  A test for differences between treatment means when several dose levels are compared with a zero dose control.

Authors:  D A Williams
Journal:  Biometrics       Date:  1971-03       Impact factor: 2.571

2.  Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice.

Authors:  D Couri; M S Abdel-Rahman; L B Hetland
Journal:  Am Ind Hyg Assoc J       Date:  1978-04

3.  Toxicity and metabolism of methyl n-butyl ketone.

Authors:  M S Abdel-Rahman; L B Hetland; D Couri
Journal:  Am Ind Hyg Assoc J       Date:  1976-02

4.  Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure.

Authors:  L Perbellini; F Brugnone; G Faggionato
Journal:  Br J Ind Med       Date:  1981-02

5.  Potentiation of 2,5-hexanedione neurotoxicity by methyl ethyl ketone.

Authors:  W H Ralston; R L Hilderbrand; D E Uddin; M E Andersen; R W Gardier
Journal:  Toxicol Appl Pharmacol       Date:  1985-11       Impact factor: 4.219

6.  Experimental studies on hydrocarbon neuropathies induced by methyl-ethyl-ketone (MEK).

Authors:  H Altenkirch; G Stoltenburg; H M Wagner
Journal:  J Neurol       Date:  1978-12-07       Impact factor: 4.849

7.  Changes of n-hexane metabolites in urine of rats exposed to various concentrations of n-hexane and to its mixture with toluene or MEK.

Authors:  M Iwata; Y Takeuchi; N Hisanaga; Y Ono
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

8.  The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man.

Authors:  N Fedtke; H M Bolt
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

9.  An experimental study of the combined effects of n-hexane and methyl ethyl ketone.

Authors:  Y Takeuchi; Y Ono; N Hisanaga; M Iwata; M Aoyama; J Kitoh; Y Sugiura
Journal:  Br J Ind Med       Date:  1983-05

10.  Changes of n-hexane neurotoxicity and its urinary metabolites by long-term co-exposure with MEK or toluene.

Authors:  M Iwata; Y Takeuchi; N Hisanaga; Y Ono
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

  10 in total
  9 in total

1.  Relationship between 2,5-hexanedione concentrations in nerve, serum, and urine alone or under co-treatment with different doses of methyl ethyl ketone, acetone, and toluene.

Authors:  W Zhao; J Misumi; T Yasui; K Aoki; T Kimura
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

2.  Pyrrole adducts in globin and plasma of workers exposed to hexane.

Authors:  Gaku Ichihara; Venkataraman Amarnath; Holly L Valentine; Tatsuya Takeshita; Kanehisa Morimoto; Tomotaka Sobue; Toshio Kawai; William M Valentine
Journal:  Int Arch Occup Environ Health       Date:  2019-04-06       Impact factor: 3.015

3.  Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione.

Authors:  A Cardona; D Marhuenda; J Martí; F Brugnone; J Roel; L Perbellini
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Determination of urinary 2,5-hexanedione concentration by an improved analytical method as an index of exposure to n-hexane.

Authors:  I Saito; E Shibata; J Huang; N Hisanaga; Y Ono; Y Takeuchi
Journal:  Br J Ind Med       Date:  1991-08

5.  2-Acetylfuran, a confounder in urinalysis for 2,5-hexanedione as an n-hexane exposure indicator.

Authors:  T Kawai; T Yasugi; K Mizunuma; S Horiguchi; Y Uchida; O Iwami; H Iguchi; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

6.  Comparison of unchanged n-hexane in alveolar air and 2,5-hexanedione in urine for the biological monitoring of n-hexane exposure in human volunteers.

Authors:  G Hamelin; G Truchon; R Tardif
Journal:  Int Arch Occup Environ Health       Date:  2004-03-13       Impact factor: 3.015

7.  Effects of MEK on kinetics of n-hexane metabolites in serum.

Authors:  E Shibata; J Huang; N Hisanaga; Y Ono; I Saito; Y Takeuchi
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

8.  Dose-dependent increase in 2,5-hexanedione in the urine of workers exposed to n-hexane.

Authors:  T Kawai; T Yasugi; K Mizunuma; S Horiguchi; Y Uchida; O Iwami; H Iguchi; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

9.  Biological exposure indices of pyrrole adducts in serum and urine for hazard assessment of n-hexane exposure.

Authors:  Hongyin Yin; Chunling Zhang; Ying Guo; Xiaoying Shao; Tao Zeng; Xiulan Zhao; Keqin Xie
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.